News from paratek pharmaceuticals, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

May 01, 2013, 15:00 ET

Paratek Pharmaceuticals Announces Expanded FDA Grant of Qualified Infectious Disease Product (QIDP) Designation for Its Lead Product Candidate, Omadacycline

Paratek Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has designated the Company's lead...

Jan 03, 2013, 12:04 ET

Paratek Pharmaceuticals Announces FDA Grant of Qualified Infectious Disease Product (QIDP) Designation for Its Lead Product Candidate, Omadacycline

Paratek Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has designated the Company's lead antibiotic...

Sep 27, 2012, 23:15 ET

Paratek Pharmaceuticals Files Registration Statement for Proposed Initial Public Offering

 Paratek Pharmaceuticals, Inc. announced today that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange...

May 22, 2012, 07:30 ET

Paratek Announces Appointments of Dennis Molnar as Chief Executive Officer and Director and of Dr. Evan Loh as Chief Medical Officer and Chairman of the Board of Directors

BOSTON, May 22, 2012 /PRNewswire/-- Paratek Pharmaceuticals, Inc. today announced that Dennis Molnar, formerly Paratek's Vice President,...

Mar 28, 2012, 08:22 ET

Paratek Wins Agreement With FDA on Special Protocol Assessment (SPA) for Phase 3 Study in Community-Acquired Bacterial Pneumonia (CABP)

 Paratek Pharmaceuticals, Inc. today announced that it has reached agreement with the U.S. Food and Drug Administration (FDA) on its second...

Sep 10, 2010, 07:30 ET

Paratek to Present Clinical Data at the 50th Interscience Conference on Antimicrobial Agents and Chemotherapy

Paratek Pharmaceuticals, Inc. today announced the Company's lead product, PTK 0796, a first-in-class aminomethylcycline, will be the subject of...

Oct 15, 2009, 07:00 ET
Oct 08, 2009, 07:00 ET

Paratek Pharmaceuticals Signs Worldwide License and Commercialization Agreement for PTK 0796, Broad-Spectrum Oral and IV Antibiotic in Phase 3

Paratek Pharmaceuticals, Inc. announced today that it has entered into an exclusive worldwide collaborative development, manufacturing and...

Jun 17, 2008, 01:00 ET

Families of Spinal Muscular Atrophy and Paratek Pharmaceuticals Extend and Expand Drug Discovery Collaboration for Spinal Muscular Atrophy

LIBERTYVILLE, Ill., and BOSTON, June 17 /PRNewswire/-- Families of Spinal Muscular Atrophy (FSMA) and Paratek Pharmaceuticals, Inc. today...

Apr 16, 2008, 01:00 ET

Paratek Pharmaceuticals Completes $40 Million Private Placement to Finance Clinical Programs Including Oral Antibiotic to Combat MRSA and Other Infections

BOSTON, April 16 /PRNewswire/ -- Paratek Pharmaceuticals, Inc. announced today that it has closed the second and final tranche of a $40 million...

Oct 25, 2007, 01:00 ET

Paratek Pharmaceuticals Announces the Close of $40 Million Private Placement to Finance Programs to Combat MRSA Infections

BOSTON, Oct. 25 /PRNewswire/ -- Paratek Pharmaceuticals, Inc. announced today that it has closed the first tranche of a $40 million private...

Sep 18, 2007, 01:00 ET

Promising Data from Paratek Pharmaceuticals' MAR Inhibitor Program Presented in 'Late Breaker' Session at the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy

BOSTON, Sept. 18 /PRNewswire/ -- Paratek Pharmaceuticals, Inc. announced today the most advanced preclinical results of the Company's Multiple...

Apr 03, 2007, 01:00 ET

Families of Spinal Muscular Atrophy and Paratek Pharmaceuticals Expand Drug Discovery Collaboration for Spinal Muscular Atrophy

LIBERTYVILLE, Ill., and BOSTON, April 3 /PRNewswire/ -- Families of Spinal Muscular Atrophy (FSMA) and Paratek Pharmaceuticals, Inc. today...

Oct 02, 2006, 01:00 ET

Paratek Pharmaceuticals Presents New Preclinical Data on Novel Aminomethylcycline Antibiotic MK-2764 at 46th Annual ICAAC

BOSTON, Oct. 2 /PRNewswire/ -- Paratek Pharmaceuticals, Inc. announced today that it presented new preclinical data on MK-2764 (formerly PTK...

May 17, 2006, 01:00 ET

Families of Spinal Muscular Atrophy and Paratek Pharmaceuticals Announce Drug Discovery Collaboration for Spinal Muscular Atrophy

LIBERTYVILLE, Ill. and BOSTON, May 17 /PRNewswire/ -- Families of Spinal Muscular Atrophy (FSMA) and Paratek Pharmaceuticals, Inc. today...

Jul 28, 2005, 01:00 ET

Paratek Pharmaceuticals Announces Phase I Trial of PTK 0796, a New Broad-Spectrum Antibiotic

BOSTON, July 28 /PRNewswire/ -- Paratek Pharmaceuticals, Inc. announced today that the Company is conducting a Phase I clinical trial of its...

Mar 03, 2005, 00:00 ET

Paratek Expands Management Team With Appointment of John P. Dunphy as CFO

BOSTON, March 3 /PRNewswire/ -- Paratek Pharmaceuticals, Inc. announced today the appointment of John P. Dunphy to the position of Vice President...

Jan 24, 2005, 00:00 ET

Paratek Announces Presentation at Piper Jaffray's Healthcare Conference

BOSTON, Jan. 24 /PRNewswire/ -- Paratek Pharmaceuticals, Inc. today announced that its Chief Executive Officer, Thomas J. Bigger, will present...

Oct 27, 2004, 01:00 ET

Paratek Pharmaceuticals Presents Multiple Sclerosis Data at Society for Neuroscience Annual Meeting

BOSTON, Oct. 27 /PRNewswire/ -- Paratek Pharmaceuticals, Inc. announced results of preclinical studies demonstrating that a new class of...

Sep 29, 2004, 01:00 ET

Paratek Announces New Board Member

BOSTON, Sept. 29 /PRNewswire/ -- Paratek Pharmaceuticals, Inc. today announced the appointment of Malcolm L. Sherman to the Company's Board of...